5-s-cysteinyldopamine has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, K; Hasegawa, K; Inoue, S; Ishihara, K; Ito, S; Wakamatsu, K | 1 |
| Ito, S; Nagatsu, T; Wakamatsu, K | 1 |
2 other study(ies) available for 5-s-cysteinyldopamine and B16 Melanoma
| Article | Year |
|---|---|
Changes in plasma 5-S-cysteinyldopa concentration in B16 melanoma-bearing mice treated with interferon-beta or dacarbazine.
Topics: Animals; Biomarkers, Tumor; Dacarbazine; Dopamine; Interferon-beta; Melanoma, Experimental; Mice; Mice, Inbred C57BL | 1993 |
Cysteinyldopamine is not incorporated into neuromelanin.
Topics: Animals; Dopamine; Hair; Humans; Hydrolysis; Melanins; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Skin; Substantia Nigra; Sulfur; Tyramine | 1991 |